NEW YORK (GenomeWeb News) – Monsanto today announced it has acquired some of the assets of genomics-based plant breeding firm Agradis, a little more than one year after the company was formed by J. Craig Venter's Synthetic Genomics and Mexican investment and management firm Plenus.

Included in the assets purchased by Monsanto are the Agradis name, its collection of microbes for improving crop productivity, and Agradis' R&D site in La Jolla, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.